OTC · BIMI
BIMI International Medical Inc.
$0.00$0.00 (0.0%)
BIMI International Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
Loading market information…
OTC · PCYS · USD
Stock price
Quote as of Oct 21, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
PrimeCare Systems, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
PrimeCare Systems, Inc., founded in 1994 and headquartered in Newport News, Virginia, specializes in the development, ownership, management, and commercialization of patient management systems, primarily within the United States. The company's core offerings include PrimeCare Version Ten, a robust multi-tiered patient management system, and CodeComplierJ. The latter is an application software designed to systematically organize patient data and accurately calculate the appropriate evaluation and management (E&M) reimbursement codes for third-party payers. PrimeCare targets a broad spectrum of healthcare providers. These include national and local health systems, military organizations, correctional facilities, and health maintenance organizations (HMOs). Additionally, the company serves hospitals with outpatient services, various ambulatory and outpatient medical facilities, clinics, group practices, and individual practitioners. Beyond its core software, PrimeCare Systems also develops, owns, maintains, and markets a suite of secure, Internet-enhanced websites that integrate with its PrimeCare System. Notable examples include PrimeCareOnTheWeb.com, an interactive platform for physicians and patients; YourOwnDoctor.com, which provides complimentary personalized websites for healthcare providers registered with PrimeCareOnTheWeb; and YourOwnHealth.com, an online resource dedicated to health and wellness. The company employs a multifaceted sales approach, focusing on direct sales to at-risk healthcare entities. It also leverages distribution channels and offers private labeling opportunities to expand its market reach.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:45 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
BIMI International Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Bionik Laboratories Corp.: Healthcare · Medical - Care Facilities.
$0.00$0.00 (0.0%)
BG Medicine, Inc.: Healthcare · Medical - Instruments & Supplies.
$0.00$0.00 (0.0%)
Millennium Sustainable Ventures Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
Grupo International Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
American Medical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
DMK Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Minerva Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
